Dihydropyridine calcium channel blockers act predominantly in the periphery, causing arterial vasodilation. Non-dihydropyridine calcium channel blockers act predominantly centrally to decrease ...

The use of potassium-sparing diuretics, inhibitors of the renin–angiotensin system, and non-dihydropyridine calcium-channel blockers different from the study drugs was not allowed. The subjects ...

Patients treated with dihydropyridine calcium channel blockers are more likely ... researchers analyzed a population with a greater portion of non-White individuals, who have been shown to be ...